80 related articles for article (PubMed ID: 10878329)
1. A simple model for the prediction of blood-brain partitioning.
Feher M; Sourial E; Schmidt JM
Int J Pharm; 2000 May; 201(2):239-47. PubMed ID: 10878329
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs.
Bhanot A; Sundriyal S
ACS Omega; 2021 Mar; 6(9):6424-6437. PubMed ID: 33718733
[TBL] [Abstract][Full Text] [Related]
3. In silico prediction of blood-brain barrier permeation.
Clark DE
Drug Discov Today; 2003 Oct; 8(20):927-33. PubMed ID: 14554156
[TBL] [Abstract][Full Text] [Related]
4. Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.
Wang W; Kim MT; Sedykh A; Zhu H
Pharm Res; 2015 Sep; 32(9):3055-65. PubMed ID: 25862462
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
[TBL] [Abstract][Full Text] [Related]
6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
7. From QSAR to QSIIR: searching for enhanced computational toxicology models.
Zhu H
Methods Mol Biol; 2013; 930():53-65. PubMed ID: 23086837
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prediction models for blood brain barrier permeability and analysis of the molecular descriptors.
Wu ZY; Pan J; Yuan Y; Hui AL; Yang Y; Zhou A
Pharmazie; 2012 Jul; 67(7):628-34. PubMed ID: 22888521
[TBL] [Abstract][Full Text] [Related]
9. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
[TBL] [Abstract][Full Text] [Related]
10. Prediction of blood-brain partitioning: a model based on molecular electronegativity distance vector descriptors.
Zhang YH; Xia ZN; Qin LT; Liu SS
J Mol Graph Model; 2010 Sep; 29(2):214-20. PubMed ID: 20637670
[TBL] [Abstract][Full Text] [Related]
11. Brain drug targeting: a computational approach for overcoming blood-brain barrier.
Mehdipour AR; Hamidi M
Drug Discov Today; 2009 Nov; 14(21-22):1030-6. PubMed ID: 19647097
[TBL] [Abstract][Full Text] [Related]
12. In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
Mensch J; Oyarzabal J; Mackie C; Augustijns P
J Pharm Sci; 2009 Dec; 98(12):4429-68. PubMed ID: 19408294
[TBL] [Abstract][Full Text] [Related]
13. Predicting blood-brain barrier penetration from molecular weight and number of polar atoms.
Fu XC; Wang GP; Shan HL; Liang WQ; Gao JQ
Eur J Pharm Biopharm; 2008 Oct; 70(2):462-6. PubMed ID: 18632257
[TBL] [Abstract][Full Text] [Related]
14. QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.
Zhang L; Zhu H; Oprea TI; Golbraikh A; Tropsha A
Pharm Res; 2008 Aug; 25(8):1902-14. PubMed ID: 18553217
[TBL] [Abstract][Full Text] [Related]
15. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
16. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
[TBL] [Abstract][Full Text] [Related]
17. QSAR models based on isomorphic and nonisomorphic data fusion for predicting the blood brain barrier permeability.
Cuadrado MU; Ruiz IL; Gómez-Nieto MA
J Comput Chem; 2007 May; 28(7):1252-60. PubMed ID: 17299834
[TBL] [Abstract][Full Text] [Related]
18. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
[TBL] [Abstract][Full Text] [Related]
19. Topochemical models for the prediction of permeability through blood-brain barrier.
Dureja H; Madan AK
Int J Pharm; 2006 Oct; 323(1-2):27-33. PubMed ID: 16815653
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of blood brain barrier permeability: an Artificial Neural Network model.
Garg P; Verma J
J Chem Inf Model; 2006; 46(1):289-97. PubMed ID: 16426064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
